68Ga-DOTATATE
Authors:
- 13 September 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 44 (11) , 851-854
Abstract
Purpose: To measure the SUVs in the tail of the pancreas compared with normal liver parenchyma and somatostatin receptor–positive lesions. Materials and Methods: 68Ga-DOTATATE PET/low mAs CT of 35 patients were reviewed. Results: There was no significant difference (P = 0.59) between the SUVaverage of normal liver and the SUVpeak of normal tail. Five patients had uptake in the tail slightly above that of normal liver that were interpreted equivocally. In one of these patients with 68Ga-DOTATATE uptake in a peripancreatic lymph node, proven neuroendocrine tumor underwent a distal pancreatectomy and pathologic examination revealed islet cell hyperplasia. Conclusions: 68Ga-DOTATATE uptake in the tail of the pancreas above that of normal liver indicates a somatostatin receptor–avid lesion. Uptake in the tail of the pancreas equal to the liver can be normal. Patients with uptake equivalent to the liver should undergo further anatomical imaging before procedural intervention.Keywords
This publication has 18 references indexed in Scilit:
- Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United StatesJAMA Oncology, 2017
- 68Ga-DOTATATE Compared with 111In-DTPA-Octreotide and Conventional Imaging for Pulmonary and Gastroenteropancreatic Neuroendocrine Tumors: A Systematic Review and Meta-AnalysisJournal of Nuclear Medicine, 2016
- Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging, and Treatment Management of Neuroendocrine TumorsJournal of Nuclear Medicine, 2016
- Somatostatin Receptor Imaging with68Ga DOTATATE PET/CT: Clinical Utility, Normal Patterns, Pearls, and Pitfalls in InterpretationRadioGraphics, 2015
- Frequency and significance of physiological versus pathological uptake of 68Ga-DOTATATE in the pancreasNuclear Medicine Communications, 2014
- Measured Human Dosimetry of68Ga-DOTATATEJournal of Nuclear Medicine, 2013
- 68Ga-labelled peptides for diagnosis of gastroenteropancreatic NETEuropean Journal of Nuclear Medicine and Molecular Imaging, 2012
- The SNM Practice Guideline for Somatostatin Receptor Scintigraphy 2.0Journal of Nuclear Medicine Technology, 2011
- NANETS Consensus Guidelines for the Diagnosis of Neuroendocrine TumorPancreas, 2010
- Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATEEuropean Journal of Nuclear Medicine and Molecular Imaging, 2010